Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19
SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,”
SHANGHAI, China, Nov. 22, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,”
PUTRAJAYA, The Unity Govt will embark on a firmer and faster form in steering
SHAH ALAM, Graduates in the field of mass communication are still in demand despite
Copyright © 2026 Cambodia News Service. All rights reserved.